CHI St. Vincent has launched a free, online heart health assessment tool so individuals can easily assess their own heart age and access a detailed report outlining their heart health risks. The launch of the CHI St. Vincent Heart Health Profiler marks the beginning of Heart Health Month and reflects the CHI St. Vincent Heart Institute’s ongoing commitment to […]

Read more

Long-term treatment with Adempas (riociguat) can reduce right heart size and improve the heart’s pumping function in patients with pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension(CTEPH), results from a retrospective study suggest. The study, “Right ventricular size and function under riociguat in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (the RIVER study),” was published at the journal Respiratory Research. Both […]

Read more

In March of 2011, Craig Lewis, 55, was dying from a heart condition that caused build-ups of abnormal proteins, and not even a pacemaker could help save his life. But two doctors from the Texas Heart Institute proposed a revolutionary new solution – install a ‘continuous flow’ device that would allow blood to circulate his […]

Read more

In recognition of Pulmonary Hypertension Awareness month, Our Founder, Ms Ayotunde Omitogun and Dr  Tosin Majekodumi (MD, Consultant Interventional Cardialogist,  Euracare Multi-specialist Hospital) were interviewed on Today on STV.  The interview was part of the #YouSabiPH campaign put together by Cardiac Community. Many Thanks to Silverbird Television for the amazing opportunity to raise awareness on this […]

Read more

Yea, we know in Naija that PH stands for Port Harcourt. Do you know? #PH also stands for Pulmonary Hypertension. Wetin be pulmonary Hypertension? Pulmonary Hypertension is a rare chronic illness that affects the lungs and heart. It is associated with high blood pressure in the arteries (pulmonary arteries) that supply blood from the heart to the […]

Read more